Zufar Mulyukov
Zufar Mulyukov
Verified email at
Cited by
Cited by
Efficiency of database search for identification of mutated and modified proteins via mass spectrometry
PA Pevzner, Z Mulyukov, V Dancik, CL Tang
Genome research 11 (2), 290-299, 2001
Automatic pathway building in biological association networks
A Yuryev, Z Mulyukov, E Kotelnikova, S Maslov, S Egorov, A Nikitin, ...
BMC bioinformatics 7, 1-13, 2006
Ionization, dissociation, and level shifts of H 2+ in a strong dc or low-frequency ac field
Z Mulyukov, M Pont, R Shakeshaft
Physical Review A 54 (5), 4299, 1996
Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration
F Grassmann, S Harsch, C Brandl, C Kiel, P Nürnberg, MR Toliat, ...
JAMA ophthalmology 137 (8), 867-876, 2019
EULER-PCR: finishing experiments for repeat resolution
Z Mulyukov, PA Pevzner
Biocomputing 2002, 199-210, 2001
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
U Schmidt-Erfurth, Z Mulyukov, BS Gerendas, GS Reiter, D Lorand, ...
Eye 37 (6), 1160-1169, 2023
Comparison of the efficacy of brolucizumab with natural disease progression in wet AMD using clinical data from the phase III HAWK and HARRIER trials and modelled placebo data
H Agostini, Z Mulyukov, M Tsilimbaris, P Calvo, F Bucher, D Gaucher, ...
Current eye research 45 (10), 1298-1301, 2020
A plateau in high-order harmonic generation for a two-level atom
VP Krainov, ZS Mulyukov
Laser Phys 4, 544, 1994
Characteristics and spatial distribution of structural features in age-related macular degeneration: a MACUSTAR Study report
M Saßmannshausen, C Behning, J Weinz, L Goerdt, JH Terheyden, ...
Ophthalmology Retina 7 (5), 420-430, 2023
Neovascular age‐related macular degeneration: a visual acuity model of natural disease progression and ranibizumab treatment effect
Z Mulyukov, S Weber, E Pigeolet, A Clemens, T Lehr, A Racine
CPT: Pharmacometrics & Systems Pharmacology 7 (10), 660-669, 2018
Breakup of H 2+ by one photon in the presence of a strong dc field
Z Mulyukov, R Shakeshaft
Physical Review A 63 (5), 053404, 2001
Effect of retinal thickness variability on visual outcomes and fluid persistence in neovascular age-related macular degeneration: a post hoc analysis of the HAWK and HARRIER …
PU Dugel, CD Jhaveri, U Chakravarthy, CC Wykoff, RP Singh, R Hamilton, ...
Retina 42 (3), 511-518, 2022
Acceleration of electrons under the ionization of atoms by focused laser pulse radiation
VP Krainov, ZS Mulyukov
Laser Physics 4 (3), 509-511, 1994
A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis
U Schmidt-Erfurth, Z Mulyukov, BSS Gerendas, P Margaron, D Lorand, ...
Investigative Ophthalmology & Visual Science 61 (7), 1159-1159, 2020
A Quasistationary State in a Zero-Range Potential Well Perturbed by a Superstrong Electric Field
VP Krainov, ZS Mulyukov
LASER PHYSICS 3 (3), 756-758, 1993
Brolucizumab 12-and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials
M Singer, AM Khanani, A Wolf, R Flores, J Chhablani, A Clemens, K Gedif, ...
Ophthalmologica 245 (4), 315-322, 2022
Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach
Y Xiong, E Pigeolet, Z Mulyukov, P Margaron, A Racine, A Clemens
Contemporary clinical trials 80, 34-39, 2019
Part I. Break Up of the Hydrogen Molecular Ion by an Electric Field. Part II. Protein Identification via Mass Spectrometry
Z Mulyukov
University of Southern California, 2000
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report
D Rowen, J Carlton, JH Terheyden, RP Finger, N Wickramasekera, ...
Value in Health 27 (5), 642-654, 2024
A computer-implemented system and method for assessing a level of activity of a disease or condition in a patient's eye
HS Chang, DFC Lorand, Z Mulyukov
US Patent App. 17/916,980, 2023
The system can't perform the operation now. Try again later.
Articles 1–20